Redwood Toxicology Laboratory, Inc.

Santa Rosa, CA Part of Alere Inc.

UEI
WEU1C4GSKD97
CAGE
4FN67
Primary NAICS
621511 Medical Laboratories
SAM.gov registration
Active through

Company facts

FY2025 rankings

Its parent company, Abbott Laboratories Inc., ranks:

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
  • Alere Inc. Parent DR3DJB88EBS7
    • Redwood Toxicology Laboratory, Inc.
SAM.gov registration date
Physical address
3650 Westwind Blvd, Santa Rosa, CA 95403, USA
Founded
1888
Employees
100K+
Estimated annual revenue
$10B+
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 -$142,519
FY2025 $144,630
FY2024 -$78,869
FY2023 -$1,018

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Redwood Toxicology Laboratory, Inc., a subsidiary of Abbott Laboratories Inc. (parent company Alere Inc.), provides urine and blood toxicology screening and testing services to federal health agencies as a prime contractor operating exclusively on full-and-open, non-set-aside awards. Based in Santa Rosa, California, the company operates across NAICS 541712 (Medical Laboratories) and PSC 84 (In Vitro Diagnostic Substances, Reagents, Test Kits and Sets), with an established federal footprint focused on diagnostic laboratory services and clinical research support.

Redwood Toxicology's customer concentration is heavily weighted toward the Department of Veterans Affairs. The Veterans Integrated Service Network 1 (VA VISN 1) accounts for 13 awards carrying $1.2 million combined potential value — the second-largest customer by dollars. However, the United States Marine Corps anchors the largest volume and dollar concentration, holding 21 awards worth $1.3 million combined potential value. These two customers alone represent 59% of Redwood Toxicology's active awards, followed by the Department of Health and Human Services Indian Health Service (9 awards, $121 thousand), the Department of the Navy Recruiting Command (6 awards, $508 thousand), and the Department of Justice US Attorney's Offices. A single GSA Federal Acquisition Service award carries $1.4 million in potential value and ranks first in dollars, though the source does not clarify whether this is a schedule position or a specific delivery order; the concentration across by-count rankings suggests this represents one large-ceiling vehicle rather than diffuse schedule activity.

Redwood Toxicology holds two active single-award indefinite-delivery contracts with VA VISN 1: a $285 thousand IDV for urine toxicology screening services through September 2029 and a $238 thousand IDV for blood toxicology testing services through April 2026 (extended through September 2029 via subsequent delivery orders). Both are non-set-aside, firm-fixed-price vehicles supporting the VA's Cooperative Studies Program research on opioid use disorder treatment and veteran healthcare delivery. The VA justified the sole-source awards on the grounds that consistent laboratory calibration and testing methodology are critical to research data validity — switching laboratories would compromise study findings. Representative delivery orders under these IDVs include a $56 thousand September 2026 urine screening order placed through West Haven, Connecticut, and a $28 thousand September 2024 blood testing order executed at Larkfield-Wikiup, California. Redwood Toxicology also provides expert witness services to the Department of Justice; a $11 thousand time-and-materials purchase order was awarded in February 2024.

Activity remains low-volume and episodic. Total awards stand at 58 across twenty years, with only one award in 2023, four in 2024, three in 2025, and one in 2026 (as of mid-September). Combined potential value across all awards is $4.6 million, with only $1.5 million obligated to date. Redwood Toxicology competes exclusively as a prime contractor (100% of awards); no subcontractor role is present in the source. The company operates entirely on non-set-aside vehicles, reflecting its positioning as a specialized diagnostic laboratory subsidiary of a large parent corporation rather than as a small-business certified vendor.

Quick answers

Is Redwood Toxicology Laboratory, Inc. registered in SAM.gov?

Yes. Redwood Toxicology Laboratory, Inc.'s SAM.gov registration is active through June 4, 2027.

How much has Redwood Toxicology Laboratory, Inc. received in federal contracts?

Federal contracts obligated $144,630 to Redwood Toxicology Laboratory, Inc. in fiscal year 2025.

How does Redwood Toxicology Laboratory, Inc. rank among federal contractors?

Redwood Toxicology Laboratory, Inc.'s parent company, Abbott Laboratories Inc., ranked #15 in PSC Q3, #16 in NAICS 621511 and #20 in NAICS 6215 in FY2025.

What is Redwood Toxicology Laboratory, Inc.'s most recent federal award?

Redwood Toxicology Laboratory, Inc.'s most recent federal contract award is Urine toxicology screening services (36C24126N0686), from Veterans Integrated Service Network 1 (VHA), on September 25, 2026.

On GovTribe

See Redwood Toxicology Laboratory, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors